AAHRPP Publishes Metrics on Performance of Human Research Protection Programs
The Association for the Accreditation of Human Research Protection Programs, Inc. announced the publication of a performance study on human research protection programs (HRPPs). The study is available in AAHRPP Advance and on the organization's Web site.
From data supplied by client organizations in 2009, AAHRPP has compiled an information database to help research organizations, researchers, sponsors, and government agencies identify and support high performance in HRPPs. One hundred ninety-six organizations, of which 8.7 percent were independent IRBs, 17.9 percent were hospitals, 27 percent were universities, 41.8 percent were VA medical centers, and 4.6 percent were other research organizations, submitted data. Following the demand for evidence-based practice in other areas, AAHRPP is leading an initiative to describe the current practices for human research protection for the research enterprise. The ultimate goal is to define and measure quality-in terms of both efficiency and the protections that organizations, IRBs, and researchers provide to research participants.
"The availability of objective data should drive bench-marking efforts to improve quality both within an organization and across the research enterprise," said Dr. Marjorie Speers, Ph.D., President and CEO. As part of the benchmarking process, individual organizations, both accredited and non-accredited, can compare their HRPPs to the aggregate of other accredited programs. Over time, they will be able to compare their current performance with their performance in the past.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
